Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In Vivo Transcriptomic Profiling using Cell Encapsulation Identifies Effector Pathways of Systemic Aging

ABSTRACT: In Vivo Transcriptomic Profiling using Cell Encapsulation Identifies Effector Pathways of Systemic Aging

PROVIDER: PRJNA797090 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17612500.fastq.gz	Fastqsanger.gz
	SRR17612501.fastq.gz	Fastqsanger.gz
	SRR17612502.fastq.gz	Fastqsanger.gz
	SRR17612503.fastq.gz	Fastqsanger.gz
	SRR17612504.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 86

Similar Datasets

In Vivo Transcriptomic Profiling using Cell Encapsulation Identifies Effector Pathways of Systemic Aging

Project description:Sustained exposure to a young systemic environment rejuvenates aged organisms and promotes cellular function. However, due to the intrinsic complexity of tissues it remains challenging to pinpoint niche-independent effects of circulating factors on specific cell populations. Here we describe a method for the encapsulation of human and mouse skeletal muscle progenitors in diffusible polyethersulfone hollow fiber capsules that can be used to profile systemic aging in vivo independent of heterogeneous short-range tissue interactions. We observed that circulating long-range signaling factors in the old systemic environment lead to an activation of Myc and E2F transcription factors, induce senescence and suppress myogenic differentiation. Importantly, in vitro profiling using young and old serum in 2D culture does not capture all pathways deregulated in encapsulated cells in aged mice. Thus, in vivo transcriptomic profiling using cell encapsulation allows for the characterization of effector pathways of systemic aging with unparalleled accuracy.

2022-03-05 | GSE193665 | GEO

In-vivo Transcriptomic Profiling of Systemic Aging using Stem Cell Encapsulation

Project description:Sustained exposure to a young systemic environment rejuvenates aged tissues and promotes stem cell function. However, due to the intrinsic complexity of tissues it remains challenging to pinpoint direct effects of circulating factors on specific cell populations. Here we describe a method for the encapsulation of human stem cells in highly diffusible polyethersulfone hollow fiber capsules that can be used to profile systemic aging independent of physical cellular interactions in-vivo.

2022-03-05 | GSE111401 | GEO

In-vivo Transcriptomic Profiling of Systemic Aging using Stem Cell Encapsulation

Project description:In-vivo Transcriptomic Profiling of Systemic Aging using Stem Cell Encapsulation

| PRJNA436920 | ENA

In vivo transcriptomic profiling using cell encapsulation identifies effector pathways of systemic aging.

Project description:Sustained exposure to a young systemic environment rejuvenates aged organisms and promotes cellular function. However, due to the intrinsic complexity of tissues it remains challenging to pinpoint niche-independent effects of circulating factors on specific cell populations. Here, we describe a method for the encapsulation of human and mouse skeletal muscle progenitors in diffusible polyethersulfone hollow fiber capsules that can be used to profile systemic aging in vivo independent of heterogeneous short-range tissue interactions. We observed that circulating long-range signaling factors in the old systemic environment lead to an activation of Myc and E2F transcription factors, induce senescence, and suppress myogenic differentiation. Importantly, in vitro profiling using young and old serum in 2D culture does not capture all pathways deregulated in encapsulated cells in aged mice. Thus, in vivo transcriptomic profiling using cell encapsulation allows for the characterization of effector pathways of systemic aging with unparalleled accuracy.

| S-EPMC8926399 | biostudies-literature

HuR coordinates systemic aging through platelet infiltration

Project description:HuR coordinates systemic aging through platelet infiltration

| PRJNA1184739 | ENA

A Virus-acquired Host Cytokine Controls Systemic Aging by Antagonizing Apoptosis

Project description:Aging is characterized by degeneration of unique tissues. However, dissecting the interconnectedness of tissue aging remains a challenge. Here, we employ a muscle-specific DNA damage model in Drosophila to reveal secreted factors that influence systemic aging in distal tissues. Utilizing this model, we uncovered a cytokine, Diedel, that when secreted from muscle or adipose can attenuate age-related intestinal tissue degeneration by promoting proliferative homeostasis of stem cells. Diedel is both necessary and sufficient to limit tissue degeneration and extend lifespan. Secreted homologs of Diedel are also found in viruses, having been acquired from host genomes. Focusing on potential mechanistic overlap between cellular aging and viral-host cell interactions and, we found that Diedel is a functionally conserved inhibitor of apoptosis and can act as a systemic rheostat to modulate cell death during aging. These results highlight a key role for secreted antagonists of apoptosis in the systemic coordination of tissue aging.

2018-07-02 | GSE111248 | GEO

HuR coordinates systemic aging through platelet infiltration

Project description:Aging involves morphological and functional changes across different organs, but how these changes are linked among the different organs remains to be elucidated. Here, we uncover a central role of platelets in sys temic aging. In aged mice, the levels of platelet secreted pro inflammatory factors (PSPF) increased greatly in the serum and platelets, leading to a diffuse increase of platelet infiltration in brain, liver, lung, kidney, and aortic root. The RNA binding protein HuR/ELAVL1, a major regulator of R NA metabolism, promoted the production of PSPF in platelets. Platelet specific deletion of HuR reduced the expression of PSPF in platelets, alleviated platelet infiltration in brain, liver, lung, kidney, and aortic root, and delayed systemic aging. Our findings highlight a role of platelets in coordinating aging traits across organs.

2024-11-16 | GSE281572 | GEO

A Virus-acquired Host Cytokine Controls Systemic Aging by Antagonizing Apoptosis

Project description:A Virus-acquired Host Cytokine Controls Systemic Aging by Antagonizing Apoptosis

| PRJNA436344 | ENA

Erucic acid improves the pregnancy complicated with systemic lupus erythematosus by inhibiting the effector function of CD8+ T cell

Project description:Pathogenic CD8+ T cells are closely related to the development of systemic lupus erythematosus. Erucic acid (EA) has been proved to have anti-inflammatory activity. However, whether EA can regulate pathogenic CD8+ T cells function in pregnancy complicated with systemic lupus erythematosus (pSLE) has not been investigated. In our study, we detected enhanced CD8+ T cell effector function and decreased EA levels in patients with pSLE compared to healthy pregnancy control. Plasma EA levels were negatively correlated with the severity complications of pSLE. In blood from patients with pSLE, EA inhibited the effector function of CD8+ T cells and the maintenance of stem cell-like memory CD8+ T cells. Mechanically, EA inhibited STAT3 phosphorylation and promoted ferroptosis, which contributed directly to the attenuated effector function of CD8+ T cells in pSLE. Moreover, EA supplementation in pregnant MRL/lpr mice inhibited the effector function of uterine CD8+ T cells and alleviated placental pathological damage. Our findings reveal the modulatory effects of EA on pathogenic CD8+ T cells from an immune response perspective, thus providing new insights into therapeutic strategy for patients with pSLE.

2025-01-01 | GSE222565 | GEO

Multiparametric characterization of red blood cells physiology after hypotonic dialysis based drug encapsulation process.

Project description:Red blood cells (RBC) can act as carriers for therapeutic agents and given their biocompatibility and long lifespan in the circulation, they can substantially improve the safety, pharmacokinetics, and pharmacodynamics of many drugs. Maintaining RBC integrity and lifespan is important for the efficacy of RBC as drug carrier and can be a complex challenge of drug encapsulation. We investigated the impact of drug encapsulation by hypotonic dialysis on RBC physiology and integrity. Several parameters were compared between processed RBC loaded with L-asparaginase (Ã¢â‚¬Å“eryaspaseÃ¢â‚¬ï¿½), processed RBC without drug and non-processed RBC. Processed RBC were less hydrated and displayed a reduction of intracellular content, relative to non-processed RBC. This reduction of intracellular content changed the RBC metabolomic profile, as indicated by the activation of the pentose phosphate pathway, but no impact on the global RBC proteomic profile was observed. We found that the encapsulation process caused moderate morphological changes and was accompanied by an increase of microparticles. Despite a decrease in their deformability, processed RBC were not mechanically retained in a spleen-mimicking device. Moreover, processed RBC had increased surface-to-volume ratio and osmotic resistance. Finally, the half-life of processed RBC was not significantly affected in a mouse model and our previous phase 1 clinical study showed that encapsulation of asparaginase in RBC prolonged its in vivo half-life compared to free form. Overall, our study demonstrated that encapsulation by hypotonic dialysis may affect certainÃ‚Â several characteristics of RBC, but does not significantly impact on the in vivo longevity of RBC or their drug carrier function.

2021-11-29 | PXD022549 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data